261 related articles for article (PubMed ID: 27323035)
1. Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis.
Pang SY; Liu HY; Huang YJ; Liu YF; Dai YM; Zeng P; Zeng HS
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323035
[TBL] [Abstract][Full Text] [Related]
2. Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).
Lipinska J; Lipinska S; Kasielski M; Smolewska E
Clin Rheumatol; 2016 Nov; 35(11):2699-2706. PubMed ID: 27457366
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
Spârchez M; Miu N; Bolba C; Iancu M; Spârchez Z; Rednic S
Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
[TBL] [Abstract][Full Text] [Related]
5. Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
Moore TL; Gillian BE; Crespo-Pagnussat S; Feller L; Chauhan AK
Clin Exp Rheumatol; 2014; 32(5):740-6. PubMed ID: 25068682
[TBL] [Abstract][Full Text] [Related]
6. [Antibodies to mutated citrullinated vimentin and some associated autoantibodies in juvenile idiopathic arthritis].
Zhang L; Ru J; Jie X; Che G; Jin X; Li X
Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):948-51. PubMed ID: 26887552
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis.
Brunner J; Sitzmann FC
Clin Exp Rheumatol; 2006; 24(4):449-51. PubMed ID: 16956438
[TBL] [Abstract][Full Text] [Related]
8. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
[TBL] [Abstract][Full Text] [Related]
9. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis.
Dewint P; Hoffman IE; Rogge S; Joos R; Union A; Dehoorne J; Delanghe J; Veys EM; De Keyser F; Elewaut D
Rheumatology (Oxford); 2006 Feb; 45(2):204-8. PubMed ID: 16188943
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis.
Kuna AT; Lamot L; Miler M; Harjacek M; Simundic AM; Vrkic N
Clin Chem Lab Med; 2009; 47(12):1525-30. PubMed ID: 19842993
[TBL] [Abstract][Full Text] [Related]
11. Anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
Brunner JK; Sitzmann FC
Mod Rheumatol; 2006; 16(6):372-5. PubMed ID: 17164999
[TBL] [Abstract][Full Text] [Related]
12. Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population.
Kwok JS; Hui KH; Lee TL; Wong W; Lau YL; Wong RW; Kim DL; Jones BM
Scand J Rheumatol; 2005; 34(5):359-66. PubMed ID: 16234183
[TBL] [Abstract][Full Text] [Related]
13. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
Habib HM; Mosaad YM; Youssef HM
Immunol Invest; 2008; 37(8):849-57. PubMed ID: 18991100
[TBL] [Abstract][Full Text] [Related]
14. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
Kasapçopur O; Altun S; Aslan M; Karaarslan S; Kamburoglu-Göksel A; Saribas S; Arisoy N; Kocazeybek B
Ann Rheum Dis; 2004 Dec; 63(12):1687-9. PubMed ID: 15547097
[TBL] [Abstract][Full Text] [Related]
16. Limitations in the classification of childhood-onset rheumatoid arthritis.
Ferrell EG; Ponder LA; Minor LS; Angeles-Han ST; Kennedy CW; Rouster-Stevens KA; Rohani-Pichavant M; Vogler LB; Prahalad S
J Rheumatol; 2014 Mar; 41(3):547-53. PubMed ID: 24488421
[TBL] [Abstract][Full Text] [Related]
17. Measurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: a comparative study.
Gilliam BE; Chauhan AK; Low JM; Moore TL
Clin Exp Rheumatol; 2008; 26(3):492-7. PubMed ID: 18578976
[TBL] [Abstract][Full Text] [Related]
18. Anti-cyclic citrullinated peptide antibodies in adult patients with juvenile idiopathic arthritis.
Skare TS; Nisihara RM; Silva RM; Munhoz da Silva DJ; Gameiro Silva MB; Utiyama SR
J Clin Rheumatol; 2011 Dec; 17(8):421-3. PubMed ID: 22089992
[TBL] [Abstract][Full Text] [Related]
19. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.
Svärd A; Kastbom A; Söderlin MK; Reckner-Olsson Å; Skogh T
J Rheumatol; 2011 Jul; 38(7):1265-72. PubMed ID: 21459947
[TBL] [Abstract][Full Text] [Related]
20. Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
Gupta R; Thabah MM; Vaidya B; Gupta S; Lodha R; Kabra SK
Indian J Pediatr; 2010 Jan; 77(1):41-4. PubMed ID: 20135267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
